Pharma Stocks
-
AstraZeneca plc stock faces pressure amid monthly declines but shows YTD strength in volatile pharma
AstraZeneca plc (ISIN: GB0009895292) shares have declined 9.88% over March 2026, ranking among monthly losers, yet boast 100.5% YTD gains.…
Read More » -
GSK plc (ADR) stock surges on FDA approval for Lynavoy as pipeline momentum builds for 2026
GSK plc (ADR) (ISIN: GB0009252882) gains attention after US FDA approves Lynavoy (linerixibat) for cholestatic pruritus on March 19, 2026.…
Read More » -
Ipca Laboratories Ltd stock hits new 52-week high amid strong earnings and analyst upgrades
Ipca Laboratories Ltd (ISIN: INE571A01038) reached a fresh 52-week high of Rs 1,624 on BSE last week, fueled by robust…
Read More » -
HOOKIPA Pharma Inc stock faces renewed scrutiny after failed merger and pipeline updates in biotech
HOOKIPA Pharma Inc (ISIN: US43906K1007) draws investor attention amid stalled merger talks with Poolbeg Pharma and ongoing clinical progress. German-speaking…
Read More » -
Pfizer Ltd stock faces headwinds amid Indian pharma market shifts and global parent pressures
Pfizer Ltd (ISIN: INE182A01018), the Indian arm of global pharma giant Pfizer Inc., grapples with recent share price declines on…
Read More » -
Eton Pharmaceuticals (ETON) Turns Q4 Profit As Trailing Losses Test Bullish Growth Narrative
Eton Pharmaceuticals (ETON) just posted its FY 2025 Q4 numbers with revenue of US$21.3 million and Basic EPS of US$0.06,…
Read More » -
Why Is Rhythm Pharma Stock Gaining Friday?
The FDA also approved Imcivree (setmelanotide) in adult and pediatric patients aged 2 years and older with syndromic or monogenic…
Read More » -
Is It Too Late To Consider Johnson & Johnson (JNJ) After A 49.8% One-Year Surge?
Some investors may be wondering whether Johnson & Johnson’s current share price still offers value, or whether most of the…
Read More » -
Pfizer vs Moderna: Which Pharma Stock Has More Upside?
Key Points The smaller, more volatile of these two companies has higher potential for significant gains. However, that also comes…
Read More » -
Pfizer vs Moderna: Which Pharma Stock Has More Upside?
Pfizer (PFE +1.26%) and Moderna (MRNA 0.39%) were both leaders in the coronavirus vaccine market. However, as sales of these…
Read More »